相关实验视频

Updated: Jan 9, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

LSP1是一种与急性髓性白血病中亡相关的预后生物标志物

Chenxing Zhang¹, Xiaomei Liang^1,2, Bangxue Jiang^1,2

¹Department of Hematology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

|December 10, 2025

概括

白细胞特异蛋白1 (LSP1) 促进急性髓性白血病 (AML) 的进展. 抑制LSP1并准NF-κB通路为AML提供了潜在的治疗策略.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

白细胞特异蛋白1 (LSP1) 与癌症进展有关.
它在急性髓性白血病 (AML) 中的特定作用和预后价值需要阐明.

研究的目的:

调查LSP1在AML中的预后意义.
探索LSP1在AML进展中的病原性作用.

主要方法:

对LSP1表达和预后价值的TCGA和GTEx数据集的分析.
qRT-PCR用于测量AML患者的LSP1水平.
在体外和体内实验中评估LSP1淘汰效应的实验.
通过GSEA和功能测试来识别相关的信号通路.

主要成果:

高LSP1表达与AML的预后不佳相关.
在体外和体内,LSP1的倒退抑制了AML细胞的生长和进展.
促进抗亡效应的NF-κB信号通路在高LSP1时受到上调,并在LSP1敲击时受到抑制.
博尔特佐米布的抗AML疗效部分取决于LSP1.

结论:

LSP1是AML进展的关键因素.
LSP1作为AML的潜在预后生物标志物.
LSP1代表了AML治疗的有前途的治疗标.

关键词:

细胞灭亡 (apoptosis) 是一种死亡的过程.博尔特佐米比 (Bortezomib) 是一种可怕的药物.一个LSP1一个LSP1 通过NF-κB信号通路传递信号.预测预后预测预测 :AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML:AML

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

相关概念视频

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...